6 Matching Annotations
  1. Feb 2026
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Addition of ipatasertib to dual anti-HER2 maintenance therapy in HER2-positive metastatic breast tumors with PIK3CA mutations: the phase 1b SOLTI-1507 IPATHER trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12869161/
  3. Mar 2023
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9975668/
  5. Aug 2021
  6. www.sciencedirect.com www.sciencedirect.com
    Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer usingnuclear morphology and tissue architecture
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121002366
  7. Nov 2018
  8. www.sciencedirect.com www.sciencedirect.com
    Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124718308635
  9. Nov 2017
  10. www.sciencedirect.com www.sciencedirect.com
    A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867416311382
  11. www.sciencedirect.com www.sciencedirect.com
    SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2352396416303632